BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2115 related articles for article (PubMed ID: 33166504)

  • 21. The prediction of fetal death with a simple maternal blood test at 20-24 weeks: a role for angiogenic index-1 (PlGF/sVEGFR-1 ratio).
    Chaiworapongsa T; Romero R; Erez O; Tarca AL; Conde-Agudelo A; Chaemsaithong P; Kim CJ; Kim YM; Kim JS; Yoon BH; Hassan SS; Yeo L; Korzeniewski SJ
    Am J Obstet Gynecol; 2017 Dec; 217(6):682.e1-682.e13. PubMed ID: 29037482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of angiogenic factors in prediction of growth-related neonatal morbidity at term and comparison with competing-risks model.
    Papastefanou I; Nobile Recalde A; Silva Souza Y; Syngelaki A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2024 Apr; 63(4):457-465. PubMed ID: 37963283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of imminent preeclampsia at 35-37 weeks gestation.
    Ciobanu A; Wright A; Panaitescu A; Syngelaki A; Wright D; Nicolaides KH
    Am J Obstet Gynecol; 2019 Jun; 220(6):584.e1-584.e11. PubMed ID: 30738886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of competing-risks model with angiogenic factors in midgestation screening for preterm growth-related neonatal morbidity.
    Papastefanou I; Menenez M; Szczepkowska A; Gungil B; Syngelaki A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2024 May; 63(5):613-618. PubMed ID: 38057964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Preeclampsia: Guidelines for clinical practice from the French College of Obstetricians and Gynecologists].
    Sentilhes L; Schmitz T; Arthuis C; Barjat T; Berveiller P; Camilleri C; Froeliger A; Garabedian C; Guerby P; Korb D; Lecarpentier E; Mattuizzi A; Sibiude J; Sénat MV; Tsatsaris V
    Gynecol Obstet Fertil Senol; 2024 Jan; 52(1):3-44. PubMed ID: 37891152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The diagnostic value of angiogenic and antiangiogenic factors in differential diagnosis of preeclampsia.
    Verlohren S; Dröge LA
    Am J Obstet Gynecol; 2022 Feb; 226(2S):S1048-S1058. PubMed ID: 33002498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maternal serum soluble fms-like tyrosine kinase-1-to-placental growth factor ratio distinguishes growth-restricted from non-growth-restricted small-for-gestational-age fetuses.
    Rajiv P; Cade T; Dean J; Jones GD; Brennecke SP
    AJOG Glob Rep; 2024 Feb; 4(1):100302. PubMed ID: 38318268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Competing risks model for prediction of small-for-gestational-age neonates from biophysical markers at 19 to 24 weeks' gestation.
    Papastefanou I; Nowacka U; Syngelaki A; Mansukhani T; Karamanis G; Wright D; Nicolaides KH
    Am J Obstet Gynecol; 2021 Nov; 225(5):530.e1-530.e19. PubMed ID: 33901487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biomarkers of impaired placentation at 35-37 weeks' gestation in the prediction of adverse perinatal outcome.
    Ciobanou A; Jabak S; De Castro H; Frei L; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Jul; 54(1):79-86. PubMed ID: 31100188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pregnancy outcomes in nulliparous women with positive first-trimester preterm preeclampsia screening test: the Great Obstetrical Syndromes cohort study.
    Boutin A; Guerby P; Gasse C; Tapp S; Bujold E
    Am J Obstet Gynecol; 2021 Feb; 224(2):204.e1-204.e7. PubMed ID: 32777265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of preeclampsia throughout gestation with maternal characteristics and biophysical and biochemical markers: a longitudinal study.
    Tarca AL; Taran A; Romero R; Jung E; Paredes C; Bhatti G; Ghita C; Chaiworapongsa T; Than NG; Hsu CD
    Am J Obstet Gynecol; 2022 Jan; 226(1):126.e1-126.e22. PubMed ID: 34998477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of new definitions of pre-eclampsia on incidence and performance of first-trimester screening.
    Khan N; Andrade W; De Castro H; Wright A; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2020 Jan; 55(1):50-57. PubMed ID: 31503372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High early pregnancy body mass index is associated with alterations in first- and second-trimester angiogenic biomarkers.
    Beck C; Allshouse A; Silver RM; Grobman WA; Simhan H; Haas D; Reddy UM; Blue NR
    Am J Obstet Gynecol MFM; 2022 May; 4(3):100614. PubMed ID: 35283347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preeclampsia at term can be classified into 2 clusters with different clinical characteristics and outcomes based on angiogenic biomarkers in maternal blood.
    Chaiworapongsa T; Romero R; Gotsch F; Suksai M; Gallo DM; Jung E; Krieger A; Chaemsaithong P; Erez O; Tarca AL
    Am J Obstet Gynecol; 2023 May; 228(5):569.e1-569.e24. PubMed ID: 36336082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
    Holme AM; Roland MC; Henriksen T; Michelsen TM
    Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic hypertension and superimposed preeclampsia: screening and diagnosis.
    Kametas NA; Nzelu D; Nicolaides KH
    Am J Obstet Gynecol; 2022 Feb; 226(2S):S1182-S1195. PubMed ID: 35177217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First trimester preeclampsia screening and prediction.
    Chaemsaithong P; Sahota DS; Poon LC
    Am J Obstet Gynecol; 2022 Feb; 226(2S):S1071-S1097.e2. PubMed ID: 32682859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of hypertensive disorders after screening at 36 weeks' gestation: comparison of angiogenic markers with competing-risks model.
    Schiattarella A; Magee LA; Wright A; Syngelaki A; Akolekar R; Von Dadelszen P; Nicolaides KH
    Ultrasound Obstet Gynecol; 2023 Sep; 62(3):345-352. PubMed ID: 37329494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of first-trimester angiogenic factors with placental histological findings in late-onset preeclampsia.
    Triunfo S; Crovetto F; Crispi F; Rodriguez-Sureda V; Dominguez C; Nadal A; Peguero A; Gratacos E; Figueras F
    Placenta; 2016 Jun; 42():44-50. PubMed ID: 27238713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biophysical and biochemical markers at 30-34 weeks' gestation in the prediction of adverse perinatal outcome.
    Valiño N; Giunta G; Gallo DM; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Feb; 47(2):194-202. PubMed ID: 26094952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 106.